Articles by Katie Anderson

  1. [VIDEO] GLP-1 Manufacturing's New Bottlenecks At Multi-Ton Scale 6/24/2026

    “At multi-ton scale, the challenge becomes less about making the molecule and more about controlling the variability of the process in this interconnected system,” explained Villain.

  2. Let Your Voice Help Shape Pharma Manufacturing 6/17/2026

    Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.

  3. Building PFMs For Scalable Manufacturing 6/17/2026

    I sat down with Rob Hughes, Ph.D., chief scientific officer at Rectify, to learn more about how PFMs work, hear about the manufacturing considerations for the technology, and learn what lies ahead for this exciting category.

  4. Can Molecular Glue Degraders Make The Undruggable Druggable? 6/12/2026

    Neomorph CEO Phil Chamberlain explains how molecular glue degraders could expand the druggable proteome and why the modality’s small-molecule profile may matter as much as its novel mechanism.

  5. Chugai Accelerates Automation To Boost Operational Efficiency 6/3/2026

    What do you do when tasked with producing drugs of different molecular sizes, including highly potent compounds, in the same facility on a global scale? You tap technological advances in automation, modular design for flexibility, and tie it together with systems that enable real-time data.

  6. Navigating Rough Pharma Seas With Collaboration 5/22/2026

    Facing geopolitical, regulatory, and operational complexity, pharma leaders are rethinking supply chains, embracing AI, and simplifying processes. Progress hinges on cross-industry collaboration and shared standards to build resilient, efficient systems.

  7. Makary's Exit Raises New Questions About FDA Stability And Direction 5/13/2026

    After serving as Commissioner of the U.S. Food and Drug Administration for a little over a year, Dr. Marty Makary resigned on May 12, 2026.

  8. [Video] Get It Right with The Gemba 5/8/2026

    The idea of the Gemba walk originated after World War II in Japan, specifically in relation to automotive production at Toyota. The word can be translated to “the real or actual place,” referring to where the work takes place—in the case of pharma or automobiles, on the factory floor.

  9. Making Mental Health Drugs: Promising Therapies And Manufacturing Challenges 4/30/2026

    Psychedelic therapies have shown promise in treating mental health disorders, but it will take close collaboration and cooperation of all related agencies and manufacturers to make this promise a reality.

  10. A 5-Step Foundation For Early CQV Involvement 4/28/2026

    All too often, a project’s issues show up in CQV, and it is there that blame is pointed. However, these issues start earlier and are entirely avoidable with proper planning.